This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
Mark Your Calendar to Join Us Next Year September 23-26, 2024
Hynes Convention Center in BostonBoston, MA
Mark Your Calendar to Join Us Next Year September 23-26, 2024|Hynes Convention Center in Boston, Boston, MA

The Cell and Gene Therapy Event for Ground-Breaking Manufacturing, Commercialization and Supply Chain Strategies

World renowned leaders share the latest bioprocessing science and technologies to improve manufacturing scalability, cost, and quality to increase access to patients in rare diseases and beyond

3000+ Global Attendees · 250+ Exhibitors · 180+ Scientific Posters · 8 Conference Tracks

Thank You to the 3000+ Attendees of CGT US 2023!

This year's event was the largest in event history, gathering 3000+ attendees and 260+ exhibitors representing 40 countries around the world. Stay updated on next year's event by signing up for email updates below. Also, be sure to attend our upcoming CGT events in 2024

Bringing you cutting edge case studies to improve efficiencies in cell and gene therapy production

Below are the main topics of the Cell & Gene Therapy Manufacturing & Commercialization 2023 event.

Cell Therapy Manufacturing

Improve process productivity, analytical characterization and reduce cost of goods in autologous cell therapy manufacturing with case study insights from Novartis, Vertex, BMS and Triumvira Immunologics Inc.

Gene Edited Ex Vivo Cell Therapy Manufacturing

Overcome scale up and manufacturing challenges in the development and commercialization of next generation “off the shelf” and gene edited products including CAR-Ts, NK cells, TCRs, TILs and iPSCs 

In Vivo Gene Therapy Manufacturing

Increase speed, consistency, scalability, and flexibility in your gene therapy manufacturing with case studies from leading gene therapy companies with approved products including Spark Therapeutics, PTC Therapeutics and bluebird bio. 

New for 2023! Supply Chain, Cryopreservation & Logistics

GSK, BMS, ElevateBio, Gamida Cell Inc. and Precision Biosciences, Inc share best practises to mitigate risk for seamless end to end supply chains and reliable distribution of CGT products

New for 2023! Well Characterized Biologics & Biological Assays

Gain practical advice from FDA, US Pharmacopeia, National Institute of Standards and Technology and industry case studies on analytical method development, characterization and validation standards for biologics and novel modalities

Co-located with the BPI International Conference & Expo

Benefit from a conference pass including access to all talks and networking opportunities for 8 conference tracks covering novel science across all phases of bioprocessing for biologics and cell & gene therapies

Get a Sneak Peek of CGT US

See what's in store for the cell & gene therapy event for ground-breaking manufacturing, commercialization, and supply chain strategies!

CONNECT WITH KEY BUYERS AT Cell & Gene Therapy 2023

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: | +44 208 052 0465

Cell & Gene Therapy Event Series